ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the ...

Banner Real Estate Group and/or its affiliated entities ("Banner"), a Chicago-based, privately held group of real estate investment and development companies, is on track to close more than $500 ...

Inthe world of investing, the biggest threat doesn’t appear on a balance sheet or an earnings report, but operates from ...

Entrada Therapeutics reported a 3Q25 GAAP EPS loss of –$1.06 and revenue of $1.6 million, reflecting declining collaboration ...

Zymeworks surges on positive Phase 3 Ziihera data in HER2-positive cancer. Discover key catalysts and what’s next for ZYME stock.

Order 4, Rule 1 of C.I. 47 allows any person claiming a remedy to bring an action. The existence of a criminal case elsewhere ...

Study shows structured AI analysis of corporate disclosures can improve stock selection and generate unique investment ...

Your 40s and 50s are critical for wealth creation. Learn the median net worth for this age group and how to prepare for retirement.